STAGE IIIA LUNG CANCER AJCC V8
Clinical trials for STAGE IIIA LUNG CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA LUNG CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA LUNG CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a vaccine stop lung cancer before it starts?
Prevention CompletedThis early-phase trial tested a vaccine called CIMAvax-EGF in 20 people at high risk for lung cancer or survivors at risk of recurrence. The vaccine works by helping the body make antibodies against a protein (EGF) that can fuel cancer growth. Researchers measured immune response…
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: Roswell Park Cancer Institute • Aim: Prevention
Last updated May 05, 2026 11:56 UTC
-
New program aims to boost resilience in older lung cancer patients
Symptom relief CompletedThis study tested a supportive care program for adults aged 60 and older with advanced lung cancer. The program combined physical therapy and relaxation exercises to help improve physical function and emotional well-being during cancer treatment. About 100 participants took part …
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 02:16 UTC
-
Cancer moonshot study banks tissue to unlock genetic secrets
Knowledge-focused CompletedThis study collected blood and tumor tissue from 64 people with advanced or treatment-resistant cancers. Researchers stored these samples to study how genes affect cancer growth and response to therapy. The goal is to better understand why some cancers stop responding to treatmen…
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC
-
Tiny heart monitor spies hidden damage during cancer radiation
Knowledge-focused CompletedThis study involved 24 people with lung or esophageal cancer receiving radiation therapy near the heart. Researchers used a small implanted device to continuously monitor heart activity for up to a year. The goal was to detect early heart changes that might otherwise go unnoticed…
Matched conditions: STAGE IIIA LUNG CANCER AJCC V8
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC